An FDA panel votes unanimously against approval for Regeneron's (REGN -0.1%) Arcalyst, saying...

|About: Regeneron Pharmaceuticals, ... (REGN)|By:, SA News Editor

An FDA panel votes unanimously against approval for Regeneron's (REGN -0.1%) Arcalyst, saying it's unsafe for the treatment of gout flares. (transcript)